161 related articles for article (PubMed ID: 32889079)
1. Ubiquitin ligase TRUSS augments the expression of interleukin-10 via proteasomal processing of NF-κB1/p105 to NF-κB/p50.
Jamal A; Husein A; Bihari C; Kumar V
Cell Signal; 2020 Nov; 75():109766. PubMed ID: 32889079
[TBL] [Abstract][Full Text] [Related]
2. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
[TBL] [Abstract][Full Text] [Related]
3. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.
Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A
Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612
[TBL] [Abstract][Full Text] [Related]
4. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50.
Ishikawa H; Claudio E; Dambach D; Raventós-Suárez C; Ryan C; Bravo R
J Exp Med; 1998 Apr; 187(7):985-96. PubMed ID: 9529315
[TBL] [Abstract][Full Text] [Related]
6. Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms.
Kravtsova-Ivantsiv Y; Goldhirsh G; Ivantsiv A; Ben Itzhak O; Kwon YT; Pikarsky E; Ciechanover A
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29823-29831. PubMed ID: 33168738
[TBL] [Abstract][Full Text] [Related]
7. Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart.
Razeghi P; Wang ME; Youker KA; Golfman L; Stepkowski S; Taegtmeyer H
Cardiovasc Res; 2007 Apr; 74(1):133-9. PubMed ID: 17276423
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1.
Zhang J; Wang K; Wang S; Zheng C
J Virol; 2013 Dec; 87(23):12935-48. PubMed ID: 24067962
[TBL] [Abstract][Full Text] [Related]
9. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
Belich MP; Salmerón A; Johnston LH; Ley SC
Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430
[TBL] [Abstract][Full Text] [Related]
10. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 docosahexaenoic acid and procyanidins inhibit cyclo-oxygenase activity and attenuate NF-κB activation through a p105/p50 regulatory mechanism in macrophage inflammation.
Martinez-Micaelo N; González-Abuín N; Terra X; Richart C; Ardèvol A; Pinent M; Blay M
Biochem J; 2012 Jan; 441(2):653-63. PubMed ID: 21954853
[TBL] [Abstract][Full Text] [Related]
12. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.
Beinke S; Ley SC
Biochem J; 2004 Sep; 382(Pt 2):393-409. PubMed ID: 15214841
[TBL] [Abstract][Full Text] [Related]
13. Coordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-κB1 p105.
Yang HT; Papoutsopoulou S; Belich M; Brender C; Janzen J; Gantke T; Handley M; Ley SC
Mol Cell Biol; 2012 Sep; 32(17):3438-51. PubMed ID: 22733995
[TBL] [Abstract][Full Text] [Related]
14. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
15. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
Lapid D; Lahav-Baratz S; Cohen S
Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages.
Cao S; Zhang X; Edwards JP; Mosser DM
J Biol Chem; 2006 Sep; 281(36):26041-50. PubMed ID: 16835236
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p105 processing by NF-kappaB proteins in transiently transfected cells.
Harhaj EW; Maggirwar SB; Sun SC
Oncogene; 1996 Jun; 12(11):2385-92. PubMed ID: 8649779
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB1: regulation and function.
Pereira SG; Oakley F
Int J Biochem Cell Biol; 2008; 40(8):1425-30. PubMed ID: 17693123
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B.
Tomczak MF; Erdman SE; Davidson A; Wang YY; Nambiar PR; Rogers AB; Rickman B; Luchetti D; Fox JG; Horwitz BH
J Immunol; 2006 Nov; 177(10):7332-9. PubMed ID: 17082652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
